444 related articles for article (PubMed ID: 25380447)
1. Allosteric targeting of receptor tyrosine kinases.
De Smet F; Christopoulos A; Carmeliet P
Nat Biotechnol; 2014 Nov; 32(11):1113-20. PubMed ID: 25380447
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation as a unifying mechanism for receptor function and regulation.
Changeux JP; Christopoulos A
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():4-21. PubMed ID: 28880476
[TBL] [Abstract][Full Text] [Related]
3. Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation.
Changeux JP; Christopoulos A
Cell; 2016 Aug; 166(5):1084-1102. PubMed ID: 27565340
[TBL] [Abstract][Full Text] [Related]
4. International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.
Christopoulos A; Changeux JP; Catterall WA; Fabbro D; Burris TP; Cidlowski JA; Olsen RW; Peters JA; Neubig RR; Pin JP; Sexton PM; Kenakin TP; Ehlert FJ; Spedding M; Langmead CJ
Pharmacol Rev; 2014 Oct; 66(4):918-47. PubMed ID: 25026896
[TBL] [Abstract][Full Text] [Related]
5. What ligand-gated ion channels can tell us about the allosteric regulation of G protein-coupled receptors.
Ehlert FJ
Prog Mol Biol Transl Sci; 2013; 115():291-347. PubMed ID: 23415097
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
7. Allosteric small molecule modulators of nuclear receptors.
Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
9. Novel Allosteric Modulators of G Protein-coupled Receptors.
Gentry PR; Sexton PM; Christopoulos A
J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Keov P; Sexton PM; Christopoulos A
Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
[TBL] [Abstract][Full Text] [Related]
11. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
Valant C; Felder CC; Sexton PM; Christopoulos A
Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
Abdul-Ridha A; Lane JR; Sexton PM; Canals M; Christopoulos A
Mol Pharmacol; 2013 Feb; 83(2):521-30. PubMed ID: 23197649
[TBL] [Abstract][Full Text] [Related]
13. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
14. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
15. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
16. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
17. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
Ortiz Zacarías NV; Lenselink EB; IJzerman AP; Handel TM; Heitman LH
Trends Pharmacol Sci; 2018 Jun; 39(6):547-559. PubMed ID: 29653834
[TBL] [Abstract][Full Text] [Related]
19. Drug Development in Channelopathies: Allosteric Modulation of Ligand-Gated and Voltage-Gated Ion Channels.
Zhang Y; Wang K; Yu Z
J Med Chem; 2020 Dec; 63(24):15258-15278. PubMed ID: 33253554
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
Müller CE; Schiedel AC; Baqi Y
Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
